active bleeding, pseudoaneurysm, true aneurysm, vascular malformation, arteriovenous fistula, and embolization in vascular intervention
Conditions
Interventions
arterial embolization with NBCA-lipiodol
Sponsors
Japan Interventional Radiology In Oncology Study Group(JIVROSG)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients who will undergo arterial embolizaiton for the pathophysiologies listed below. Active bleeding or pseudoaneurysm True aneurysm Vascuar malformation Arteriovenous fistula Arterial re-distribution 2. Difficulties in embolization with pre-existing embolic materials approved in Japan judged by radiologists. or Failures of embolization with pre-existing embolic materials approved in Japan. 3. Shock index < 1.5 4.Written informe consent is obtained from patients or their relatives.
Exclusion criteria
Exclusion criteria: 1. Allergic histories for iodininated contrast medium or lipiodol. 2. CNS arteriovenous malformation 3. Cerebral aneurysm 4. DIC 5. Uncontrollable shock 6. Endoleak after aortic stent placement 7. Pregnant woman, or pegnancy is suspected 8. Radiologist judged that the patients is not suitable for the present study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy: Success rate of embolization with NBCA-lipiodol mixture | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety: Frequency of adverse events | — |
Countries
Japan
Contacts
Public ContactShunsuke Sugawara
National Cancer Center Diagnostic Radiology
Outcome results
None listed